Martin Crook

7.2k total citations · 1 hit paper
163 papers, 4.9k citations indexed

About

Martin Crook is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Martin Crook has authored 163 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Surgery, 43 papers in Endocrinology, Diabetes and Metabolism and 30 papers in Genetics. Recurrent topics in Martin Crook's work include Lipoproteins and Cardiovascular Health (28 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (27 papers) and Diabetes and associated disorders (23 papers). Martin Crook is often cited by papers focused on Lipoproteins and Cardiovascular Health (28 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (27 papers) and Diabetes and associated disorders (23 papers). Martin Crook collaborates with scholars based in United Kingdom, Canada and United States. Martin Crook's co-authors include John C. Pickup, P. Tutt, P Lumb, Anthony S. Wierzbicki, M. Haq, Mark Ide, P Y Coward, Michael M. Meguid, Krishnan Sriram and R. F. Wilson and has published in prestigious journals such as The Lancet, Diabetes Care and The American Journal of Medicine.

In The Last Decade

Martin Crook

155 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Is Type II diabetes mellitus a disease of the innate immune system?

1998 831 citations John C. Pickup, Martin Crook profile →

Peers

Countries citing papers authored by Martin Crook

Since Specialization

Citations

This map shows the geographic impact of Martin Crook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Crook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Crook more than expected).

Fields of papers citing papers by Martin Crook

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Crook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Crook. The network helps show where Martin Crook may publish in the future.

Co-authorship network of co-authors of Martin Crook

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Crook. A scholar is included among the top collaborators of Martin Crook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Crook. Martin Crook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Age- and ethnicity-related reference intervals for serum vitamin B12 2022 ·Clinical Biochemistry ·Agata Sobczyńska‐Malefora, (unknown), David L. Steed, (unknown), Martin Crook, Dominic J. Harrington	9
2	Review of referral criteria to lipid clinics and outcomes of treatment in four UK centres 2018 ·International Journal of Clinical Practice ·Anthony S. Wierzbicki, Adie Viljoen, (unknown), Steven C. Martin, Martin Crook, Tim Reynolds	2
3	Pro-protein subtilisin kexin-9 (PCSK9) inhibition in practice: lipid clinic experience in 2 contrasting UK centres 2017 ·International Journal of Clinical Practice ·(unknown), (unknown), (unknown), Radha Ramachandran, Martin Crook, Tim Reynolds, Anthony S. Wierzbicki	28
4	Management and prevention of refeeding syndrome in medical inpatients: An evidence-based and consensus-supported algorithm 2017 ·Nutrition ·Natalie Friedli, Zeno Stanga, Alison Culkin, Martin Crook, Alessandro Laviano, L. Sobótka, Reto W. Kressig, Jens Kondrup, Beat Müeller, Philipp Schüetz	98
5	Acute pancreatitis associated with severe hypertriglyceridaemia; A retrospective cohort study 2015 ·International Journal of Surgery ·(unknown), A. C. Steger, Martin Crook	36
6	Seasonal factitious increase in serum potassium: Still a problem and should be recognised 2014 ·Clinical Biochemistry ·(unknown), Martin Crook	7
7	Patient accounts of diagnostic testing for familial hypercholesterolaemia: comparing responses to genetic and non-genetic testing methods 2012 ·BMC Medical Genetics ·Gareth J Hollands, David Armstrong, (unknown), Martin Crook, Theresa M. Marteau	12
8	A prospective case-controlled cohort study of endothelial function in patients with moderate to severe psoriasis 2010 ·British Journal of Dermatology ·(unknown), Ranthilaka R. Ranawaka, Phil Chowienczyk, Martin Crook, Michael Marber, Catherine Smith, Juliet N. Barker	30
9	The incidence of low eGFR and proteinuria in a large tertiary referral lipid clinic 2010 ·International Urology and Nephrology ·(unknown), Martin Crook, Anthony S. Wierzbicki, David Goldsmith	1
10	A prospective case-controlled cohort study to assess pre-clinical cardiovascular disease in patients with moderate to severe psoriasis 2009 ·Journal of Investigative Dermatology ·(unknown), Ranthilaka R. Ranawaka, Martin Crook, Michael Marber, Phil Chowienczyk, Catherine Smith, Juliet N. Barker	1
11	Cardiovascular disease in renal allograft recipients is associated with elevated sialic acid or markers of inflammation 2004 ·Clinical Transplantation ·(unknown), Behdad Afzali, Adrian Covic, (unknown), (unknown), (unknown), (unknown), Neil Dalton, Anthony S. Wierzbicki, Martin Crook, David Goldsmith	26
12	The prevalence of diabetes related complications amongst the Turkish diabetes population attending a south London hospital 2002 ·Practical Diabetes International ·(unknown), Martin Crook, (unknown)	0
13	Clinical governance and pathology 2002 ·Journal of Clinical Pathology ·Martin Crook	6
14	Handbook of near-patient testing 1999 ·Martin Crook	2
15	Growth hormone (GH) replacement therapy reduces serum sialic acid concentrations in adults with GH‐deficiency: a double‐blind placebo‐controlled study 1999 ·Clinical Endocrinology ·Emanuel Christ, Michael H. Cummings, P Lumb, Martin Crook, Peter H. Sönksen, David Russell‐Jones	19
16	Plasma sialic acid and coronary artery atheromatous load in patients with stable chest pain 1999 ·Atherosclerosis ·Eugene B. Wu, P Lumb, John B. Chambers, Martin Crook	18
17	Fenofibrate plus simvastatin therapy versus simvastatin plus cholestyramine therapy for familial hypercholesterolaemia 1997 ·QJM ·(unknown), P Lumb, J Cheung, Martin Crook	17
18	Serum sialic acid as an indicator of change in coronary artery disease 1995 ·Metabolism ·Gerald F. Watts, Martin Crook, (unknown), Sundhiya Mandalia	35
19	Erythrocyte, plasma total, ultrafiltrable and platelet magnesium in type 2 (non-insulin dependent) diabetes mellitus. 1994 ·PubMed ·Martin Crook, (unknown), P. Tutt, Stephanie A. Amiel, R. Swaminathan	11
20	Blood Glucose and Glycated Haemoglobin Measurement in Hospital: Which Method? 1993 ·Diabetic Medicine ·John C. Pickup, Martin Crook, P. Tutt	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact